SIMILAR PATTERNS OF AMINO ACIDS FOR 3G4L_A_ROFA901_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 736HIS A 737PRO A 941SER A 990PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.6A) | 1.25A | 3g4lA-1sojA:42.0 | 3g4lA-1sojA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 736HIS A 737PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.53A | 3g4lA-1sojA:42.0 | 3g4lA-1sojA:32.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xkh | FERRIPYOVERDINERECEPTOR (Pseudomonasaeruginosa) |
PF00593(TonB_dep_Rec)PF07715(Plug) | 5 | HIS A 324ASN A 384PRO A 367SER A 440PHE A 503 | None | 1.33A | 3g4lA-1xkhA:undetectable | 3g4lA-1xkhA:19.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 211HIS A 212ASN A 365PRO A 366TRP A 376PHE A 416 | IBM A 503 (-4.6A)NoneIBM A 503 ( 4.7A)NoneNoneIBM A 503 (-3.4A) | 0.42A | 3g4lA-1zklA:45.4 | 3g4lA-1zklA:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1znp | HYPOTHETICAL PROTEINATU3615 (Agrobacteriumfabrum) |
PF06172(Cupin_5) | 5 | TYR A 25HIS A 19THR A 28ILE A 43SER A 40 | None | 1.31A | 3g4lA-1znpA:undetectable | 3g4lA-1znpA:16.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 371HIS A 372MET A 485ASN A 533PRO A 534TYR A 541TRP A 544THR A 545ILE A 548MET A 569SER A 580PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A)NoneNPV A 3 (-4.4A)NoneNoneNoneNPV A 3 ( 4.7A)NPV A 3 (-3.8A)NPV A 3 (-3.1A)NPV A 3 (-4.5A)NPV A 3 (-3.3A) | 0.49A | 3g4lA-2qykA:51.8 | 3g4lA-2qykA:85.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 281HIS A 282MET A 395ASN A 443PRO A 444TRP A 454THR A 455ILE A 458PHE A 494 | None | 0.59A | 3g4lA-2qymA:43.1 | 3g4lA-2qymA:83.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 281HIS A 282MET A 395ASN A 443PRO A 444TYR A 451TRP A 454THR A 455PHE A 494 | None | 0.60A | 3g4lA-2qymA:43.1 | 3g4lA-2qymA:83.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 6 | TYR A 680HIS A 681MET A 797ASN A 838TRP A 849PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)NoneIBM A 3 (-4.5A)NoneIBM A 3 (-3.6A) | 0.40A | 3g4lA-2r8qA:38.8 | 3g4lA-2r8qA:29.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 5 | MET A 670ASN A 729PRO A 730SER A 780PHE A 781 | IBM A 3 (-4.5A)NoneNoneNoneIBM A 3 (-3.5A) | 1.01A | 3g4lA-3ecnA:44.8 | 3g4lA-3ecnA:32.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 555HIS A 556MET A 670ASN A 729PRO A 730TRP A 740ILE A 744SER A 777PHE A 781 | NoneNoneIBM A 3 (-4.5A)NoneNoneNoneIBM A 3 (-4.3A)NoneIBM A 3 (-3.5A) | 0.43A | 3g4lA-3ecnA:44.8 | 3g4lA-3ecnA:32.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 326MET A 439MET A 523SER A 534PHE A 538 | D71 A 901 (-4.5A)D71 A 901 ( 4.0A)D71 A 901 ( 4.0A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 1.03A | 3g4lA-3g4gA:52.5 | 3g4lA-3g4gA:74.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 325HIS A 326MET A 439ASN A 487PRO A 488TYR A 495TRP A 498THR A 499ILE A 502MET A 523PHE A 538 | NoneD71 A 901 (-4.5A)D71 A 901 ( 4.0A)D71 A 901 (-4.5A)NoneNoneNoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 ( 4.0A)D71 A 901 (-3.9A) | 0.61A | 3g4lA-3g4gA:52.5 | 3g4lA-3g4gA:74.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 233HIS A 234MET A 347ASN A 395PRO A 396TYR A 403TRP A 406THR A 407ILE A 410MET A 431SER A 442PHE A 446 | NoneNoneZG2 A 506 (-3.9A)ZG2 A 506 (-4.3A)ZG2 A 506 ( 4.5A)NoneNoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)ZG2 A 506 (-3.4A)NoneZG2 A 506 (-3.6A) | 0.53A | 3g4lA-3o57A:51.6 | 3g4lA-3o57A:80.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qi3 | HIGH AFFINITYCGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 9A (Homo sapiens) |
PF00233(PDEase_I) | 5 | HIS A 252MET A 365ASN A 405TRP A 416PHE A 456 | PDB A 600 (-4.6A)PDB A 600 ( 4.7A)PDB A 600 (-4.4A)NonePDB A 600 (-3.5A) | 0.58A | 3g4lA-3qi3A:41.8 | 3g4lA-3qi3A:24.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rko | NADH-QUINONEOXIDOREDUCTASESUBUNIT L (Escherichiacoli) |
no annotation | 5 | MET L 432TYR L 102ILE L 353MET L 243SER L 250 | None | 1.37A | 3g4lA-3rkoL:undetectable | 3g4lA-3rkoL:21.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 10 | TYR A 159HIS A 160ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASN A 321 (-0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.52A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 159HIS A 160MET A 273ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASN A 321 (-0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.44A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 6 | TYR A 367HIS A 368MET A 482TRP A 535ILE A 538PHE A 573 | WYQ A 701 (-4.5A)NoneWYQ A 701 (-4.5A)NoneWYQ A 701 ( 4.1A)WYQ A 701 (-3.4A) | 0.75A | 3g4lA-3v94A:39.7 | 3g4lA-3v94A:30.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 6 | TYR A 668HIS A 669MET A 785ASN A 825TRP A 836PHE A 877 | None | 0.44A | 3g4lA-4i15A:38.2 | 3g4lA-4i15A:32.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4udj | UHGB_MP (unculturedorganism) |
PF04041(Glyco_hydro_130) | 5 | TYR A 300ASN A 28PRO A 29THR A 307SER A 41 | NoneNonePGE A 608 (-3.8A)None K A 606 (-2.6A) | 1.27A | 3g4lA-4udjA:undetectable | 3g4lA-4udjA:19.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406MET A 519ASN A 567PRO A 568TRP A 578THR A 579ILE A 582MET A 603SER A 614PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNoneNoneNone | 0.74A | 3g4lA-4wziA:52.2 | 3g4lA-4wziA:47.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406MET A 519ASN A 567PRO A 568TYR A 575TRP A 578THR A 579MET A 603SER A 614PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNoneNoneNone | 0.60A | 3g4lA-4wziA:52.2 | 3g4lA-4wziA:47.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z81 | EGF FAMILYDOMAIN-CONTAININGPROTEIN (Toxoplasmagondii) |
PF02430(AMA-1)PF07974(EGF_2) | 5 | ASN A 171THR A 167MET A 373SER A 164PHE A 156 | None | 1.47A | 3g4lA-4z81A:undetectable | 3g4lA-4z81A:20.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 222HIS A 223MET A 336PRO A 374TRP A 384THR A 385SER A 420PHE A 424 | None4QJ A 603 ( 4.9A)4QJ A 603 ( 3.9A)NoneNoneNone4QJ A 603 (-4.7A)4QJ A 603 (-3.5A) | 0.43A | 3g4lA-5b25A:43.8 | 3g4lA-5b25A:37.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 5 | MET A 785ASN A 826TRP A 837MET A 862PHE A 878 | LLN A1003 (-4.0A)LLN A1003 (-4.4A)NoneLLN A1003 (-3.5A)LLN A1003 (-3.8A) | 0.98A | 3g4lA-5h2rA:38.8 | 3g4lA-5h2rA:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 6 | TYR A 668HIS A 669MET A 785ASN A 826TRP A 837PHE A 878 | LLN A1003 ( 4.8A)NoneLLN A1003 (-4.0A)LLN A1003 (-4.4A)NoneLLN A1003 (-3.8A) | 0.34A | 3g4lA-5h2rA:38.8 | 3g4lA-5h2rA:31.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 9 | TYR A 405ASN A 567PRO A 568TYR A 575TRP A 578THR A 579ILE A 582MET A 603PHE A 618 | None9VE A 801 (-4.1A)9VE A 801 (-3.9A)9VE A 801 (-4.6A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-3.6A)9VE A 801 (-3.9A) | 0.68A | 3g4lA-5ohjA:51.7 | 3g4lA-5ohjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406MET A 519ASN A 567PRO A 568TYR A 575TRP A 578THR A 579ILE A 582SER A 614PHE A 618 | NoneNone9VE A 801 (-3.8A)9VE A 801 (-4.1A)9VE A 801 (-3.9A)9VE A 801 (-4.6A)None9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-4.7A)9VE A 801 (-3.9A) | 0.27A | 3g4lA-5ohjA:51.7 | 3g4lA-5ohjA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 5 | HIS A 83MET A 195ASN A 239PRO A 240PHE A 291 | None | 0.71A | 3g4lA-5vydA:39.6 | 3g4lA-5vydA:30.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 11 | TYR A 159HIS A 160MET A 273ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357PHE A 372 | AKJ A 601 ( 4.7A)NoneAKJ A 601 ( 3.9A)AKJ A 601 (-4.3A)AKJ A 601 (-3.9A)AKJ A 601 (-4.8A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-4.1A) | 0.42A | 3g4lA-5wh6A:54.2 | 3g4lA-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 9 | TYR A 159HIS A 160PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | AKJ A 601 ( 4.7A)NoneAKJ A 601 (-3.9A)AKJ A 601 (-4.8A)NoneAKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-2.5A) | 0.66A | 3g4lA-5wh6A:54.2 | 3g4lA-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjh | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 99TYR A 69THR A 110ILE A 83SER A 92 | None | 1.08A | 3g4lA-5xjhA:undetectable | 3g4lA-5xjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjh | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 99TYR A 69THR A 110ILE A 83SER A 93 | None | 1.30A | 3g4lA-5xjhA:undetectable | 3g4lA-5xjhA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yfb | DIPEPTIDYL PEPTIDASE3 (Armillariatabescens) |
no annotation | 5 | TYR A 276HIS A 288ILE A 307SER A 375PHE A 326 | None | 1.11A | 3g4lA-5yfbA:undetectable | 3g4lA-5yfbA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ane | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 72TYR A 42THR A 83ILE A 56SER A 65 | None | 1.06A | 3g4lA-6aneA:undetectable | 3g4lA-6aneA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ane | POLY(ETHYLENETEREPHTHALATE)HYDROLASE (Ideonellasakaiensis) |
no annotation | 5 | PRO A 72TYR A 42THR A 83ILE A 56SER A 66 | None | 1.31A | 3g4lA-6aneA:undetectable | 3g4lA-6aneA:undetectable |